PB 16 of 2021

National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2021 (No. 2)

I, THEA CONNOLLY, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, and delegate of the Minister for Health and Aged Care make the following determination.

Dated    24 February  2021

THEA CONNOLLY  

Contents

1 Name

2 Commencement

3 Authority

4  Schedule

Schedule 1—Amendments 2

National Health (Continued Dispensing - Emergency Measures) Determination 2020 2

1  Name

(1)  This instrument is the National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2021 (No. 2).

(2)  This instrument may also be cited as PB 16 of 2021.

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

  This instrument is made under subsection 89A(3) of the National Health Act 1953.

4  Schedules

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Continued Dispensing – Emergency Measures) Determination 2020

[1]           Schedule 1, omit entry for Amino acid formula with fat, carbohydrate, vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine and supplemented with docosahexaenoic acid

[2]           Schedule 1, after entry for Amino acid formula with vitamins and minerals without methionine in the form Sachets containing oral powder 25 g, 30 (HCU express 15)

insert:

[3]           Schedule 1, after entry for Amino acid formula with vitamins and minerals without phenylalanine and tyrosine in the form Sachets containing oral powder 25 g, 30 (TYR express 15)

insert:

[4]           Schedule 1, after entry for Amino acid formula with vitamins and minerals without valine, leucine and isoleucine in the form Sachets containing oral powder 25 g, 30 (MSUD express 15)

insert:

[5]           Schedule 1, entry for Captopril

omit:

[6]           Schedule 1, omit entry for Cefalotin

[7]           Schedule 1, omit entry for Cimetidine

[8]           Schedule 1, after entry for Desmopressin in the form Intranasal solution containing desmopressin acetate 100 micrograms per mL, 2.5 mL dropper bottle  

insert:

[9]           Schedule 1, after entry for Duloxetine in the form Capsule 60 mg (as hydrochloride)

insert:

[10]       Schedule 1, entry for Erythromycin

omit:

[11]       Schedule 1, omit entry for Grazoprevir with elbasvir

[12]       Schedule 1, after entry for Indacaterol with glycopyrronium

insert:

[13]       Schedule 1, omit entry for Metformin with glibenclamide

[14]       Schedule 1, after entry for Oxycodone with naloxone in the form Tablet (controlled release) containing oxycodone hydrochloride 80 mg with naloxone hydrochloride 40 mg

insert:

[15]       Schedule 1, omit entry for Sucralfate

[16]       Schedule 1, entry for Tamoxifen

omit:

[17]       Schedule 1, entry for Verapamil

omit: